Instituto de Salud Carlos III (ISCIII) is the leading Public Research Organization in Spain, dedicated to funding, managing, and conducting biomedical research. With over 30 years of experience, ISCIII has been at the forefront of research and the provision of key services in life sciences and health. Its primary mission is to support the development of scientific knowledge in health sciences and to contribute to innovation in healthcare and disease prevention. ISCIII’s Centers and Units, recognized nationally and internationally, carry out research activities in biomedicine, environmental health, and public health. Among them is the National Centre for Microbiology (CNM), devoted to basic and applied research in the prevention, diagnosis, and treatment of human infectious diseases.

ISCIII contributes to the network by providing diagnostic and reference services related to human infectious pathogens in addition to its microbial collection. Specifically, the Reference and Research Laboratory in Mycology offers a wide range of diagnostic services, including identification and antifungal susceptibility testing, therapeutic drug monitoring of antifungals, antibody detection, and typing of major human fungal pathogens. To ensure the quality of its services and resources, CNM maintains a rigorous quality management system aligned with international standards such as ISO 17025, ISO 9001, and ISO 15189 under flexible scope. LRIM has been accredited by ENAC under ISO 15189 since 2008, with all services included in the accreditation. ISCIII has been actively involved in numerous European and international initiatives, collaborating with other microbial Biological Resource Centres (mBRCs) to share best practices and experiences. Through these collaborations, ISCIII acts as a bridge between Spain and international efforts in this field, enhancing Europe’s competitiveness in biotechnology and public health.

Contact email: Ana Alastruey-Izquierdo